Charles River Laboratories | CRL - Ordinary Share Capital

Stock Price
150.85
Daily Change
-8.27 -5.20%
Monthly
-14.75%
Yearly
7.01%
Q2 Forecast
173.94

Charles River Laboratories reported $48.17M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Agilent USD 282.7M 358K Dec/2025
Align Technology USD 71.62M 133K Mar/2026
Bio-Rad Laboratories USD 26.99M 18K Dec/2025
Bruker USD 152.22M 282K Mar/2026
Cardinal Health USD 235M 1000K Mar/2026
Charles River Laboratories USD 48.17M 1.05M Mar/2026
Cigna USD 264.6M 1.14M Mar/2026
Concord Medical Services Hldg CNY 130.25M 130.15M Jun/2025
CVS Health USD 1.27B 2M Mar/2026
Danaher USD 707.7M 800K Mar/2026
Dentsply International USD 200.3M 700K Mar/2026
Elevance Health USD 217.37M 4.87M Mar/2026
Humana USD 120.06M 529K Mar/2026
Illumina USD 151.91M 893K Mar/2026
Incyte USD 199.95M 1.49M Mar/2026
Intrexon USD 0 0 Jun/2024
IQVIA Holdings USD 166.9M 2.7M Mar/2026
Laboratory Of America USD 82.3M 100K Mar/2026
Lakefront Biotherapeutics EUR 65.9M 0 Mar/2026
Lonza CHF 68.64M 0 Dec/2025
McKesson USD 280M 156M Dec/2025
Merck EUR 434.78M 0 Dec/2025
Mettler Toledo International USD 20.25M 179.94K Mar/2026
Novartis USD 1.91B 60K Mar/2026
Pfizer USD 5.7B 13M Mar/2026
Quest Diagnostics USD 111M 1000K Mar/2026
Revvity USD 111.8M 1.57M Mar/2026
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
United Therapeutics USD 42.16M 1.49M Mar/2026
UnitedHealth USD 907.68M 1.84M Mar/2026
Veradigm USD 106.07M 103.28M Dec/2022
Waters USD 98.17M 89K Mar/2026
West Pharmaceutical Services USD 70.9M 1.1M Mar/2026